Skip to main content
All tenders

Non-exclusive Discount Agreements for Patented Active Ingredients

Status
Active
Submission Deadline
354 days remaining
Contracting authority
GWQ ServicePlus AG49 more open tenders view
Location
Düsseldorf, Germany
Procedure
Open Procedure · Supplies
Category
Pharmaceutical products.
Published
Reference
ted-575544-2026

Non-exclusive discount agreements according to § 130a para. 8 or § 130c para. 8 SGB V for patented active ingredients: contract start on 01.10.2026. All interested companies can join the contract at any time under the same conditions (admission model). Required documents: signed contract (duplicate or QES), proof of pharmaceutical marketing authorization (excerpt from AMIce database), list of contract-relevant PZN (Annex 5), signed self-declaration (Annex 6), self-declaration on EU regulation (Annex 7). Contract documents, participating health insurance funds, revenues, and registration deadlines are available on the GWQ ServicePlus AG procurement portal.

Free

Never miss a tender again

We send you 3 current matches that fit your company.

With a number we call briefly to sharpen your search profile.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email and, if you leave a number, calls you once about it. Revocable at any time. Privacy policy


Tender documents

  • Portal — LOT-0001NON-RESTRICTED-DOCUMENT
  • TED HTML — 575544-2026HTML
  • TED PDF — 575544-2026PDF
  • TED XML — 575544-2026XML
Free

Unlock documents for free

Enter your email address. If you confirm, we will also send you 3 similar tenders.

No account neededReply in 1-2 business days

By submitting, you agree that Patterno sends you matching tenders by email. Free, unsubscribe anytime. Privacy policy


Lots (18)

  • LOT-0001Nicht-exklusive Rabattvereinbarung für den Wirkstoff Anakinra
  • LOT-0002Nicht-exklusive Rabattvereinbarung für den Wirkstoff Ciclosporin S01XA18 (VEVIZYE & CEQUA)
  • LOT-0003Nicht-exklusive Rabattvereinbarung für den Wirkstoff Clostridium botulinum Toxin Typ A (Botox)
  • LOT-0004Nicht-exklusive Rabattvereinbarung für den Wirkstoff Etrasimod
  • LOT-0005Nicht-exklusive Rabattvereinbarung für den Wirkstoff Allergen-Extrakt (Grazax)
  • LOT-0006Nicht-exklusive Rabattvereinbarung für den Wirkstoff Pegvisomant
  • LOT-0007Nicht-exklusive Rabattvereinbarung für den Wirkstoff Ponesimod
  • LOT-0008Nicht-exklusive Rabattvereinbarung für den Wirkstoff Propranolol (Hemangiol)
  • LOT-0009Nicht-exklusive Rabattvereinbarung für den Wirkstoff Rilpivirin (FTA)
  • LOT-0010Nicht-exklusive Rabattvereinbarung für den Wirkstoff Risankizumab
  • LOT-0011Nicht-exklusive Rabattvereinbarung für den Wirkstoff Siponimod
  • LOT-0012Nicht-exklusive Rabattvereinbarung für den Wirkstoff Somatropin (Humatrope/ Norditropin/ Saizen)
  • LOT-0013Nicht-exklusive Rabattvereinbarung für den Wirkstoff Tiotropium (INL)
  • LOT-0014Nicht-exklusive Rabattvereinbarung für die Wirkstoffkombination Tiotropium + Olodaterol
  • LOT-0015Nicht-exklusive Rabattvereinbarung für den Wirkstoff Interferon beta-1b (Betaferon)
  • LOT-0016Nicht-exklusive Rabattvereinbarung für den Wirkstoff Triptorelin (Pamorelin)
  • LOT-0017Nicht-exklusive Rabattvereinbarung für den Wirkstoff Ozanimod
  • LOT-0018Nicht-exklusive Rabattvereinbarung für den Wirkstoff Filgotinib

Additional details

EU Funded
Yes
Suitable for SMEs
No
Electronic Submission
Allowed
Legal Basis
32014L0024
Live webinar

See Patterno work on a real tender

45 minutes live, questions answered in the chat. Upcoming dates on the signup page.

  • Matches from 4,500+ portals in one workspace
  • Qualify any tender against your criteria in minutes
  • Prepare bid documents from your company context

Prefer a private session?